BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12417089)

  • 21. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia.
    Magyarosy E; Sebestyén A; Timár J
    Anticancer Res; 2001; 21(1B):819-23. PubMed ID: 11299850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
    Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
    Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The expression of nm23-H1 genes with clinical prognosis in endometrial carcinoma].
    Guo C; Wei L; Fu Q
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):423-5. PubMed ID: 11360656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
    Huang Y; Cai S; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
    Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
    Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
    Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
    Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NM23 protein in neoplastic and nonneoplastic thyroid tissues.
    Bertheau P; De La Rosa A; Steeg PS; Merino MJ
    Am J Pathol; 1994 Jul; 145(1):26-32. PubMed ID: 8030752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.
    Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
    Eur J Cardiothorac Surg; 2001 Jun; 19(6):904-7. PubMed ID: 11404150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
    Watanabe J; Sato Y; Kuramoto H; Kameya T
    Br J Cancer; 1995 Dec; 72(6):1469-73. PubMed ID: 8519661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
    Lin LI; Lee PH; Wu CM; Lin JK
    Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and localization of nm23-H1 in the human placenta.
    Okamoto T; Iwase K; Niu R
    Arch Gynecol Obstet; 2002 Jan; 266(1):1-4. PubMed ID: 11998956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma].
    Liang C; Xu G
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):391-3. PubMed ID: 11387948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
    Lindmark G
    Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
    Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
    Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.